Companies claim e-cigarettes can deliver nutrients, but experts say the science looks shaky
Xofluza is the first drug with a new mechanism of action to be approved in nearly 20 years
Director Robert Redfield declined to comment directly on the policy, which would define someone’s sex at birth
Suspicions humans are consuming tiny plastic particles have been confirmed, spurring future work into the possible health impacts
Could proposals for all-encompassing health coverage become empty campaign slogans?
Researchers have traced some cases of acute flaccid myelitis to a known virus, but treatments remain elusive
Less than half of the products were recalled, a U.S. Food and Drug Administration analysis found
The search is on for safe, effective ways to taper the drugs for people in chronic pain
Preeclampsia can be treated, yet screenings are out of reach for many women
Some states let them deny care for nonmedical reasons
Work suggests preparedness strategy should differ by location
The president plans to send a test message in a system that would notify Americans of an imminent attack or other catastrophe
Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann talks about the just-issued Goalkeepers Report, tracking progress against poverty and disease even as the population keeps rising.
Researchers have designed a musical instrument that can detect counterfeit drugs by the pitch of its notes. Christopher Intagliata reports.
More than 100 people have become ill with diarrheal disease
Government data provides fresh snapshot of annual drug-use behavior
Scientists scoured variants of BRCA1 to determine which are pathogenic
As Trump calls for new bomb production, the administration cuts safety board access to nuclear facilities
Up to 10,000 bugs could be deployed
A still-experimental drug demonstrates the qualities of an ideal painkiller in a test in monkeys